Today's Low
₹ 90.80
Today's High
₹ 96.50
52 Weeks Low
₹ 95.25
52 Weeks High
₹ 173.00
Lower
₹ 74.80
Upper
₹ 112.20
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 206.6 | 185.0 | 133.9 | 119.2 | 105.0 | 122.8 | 95.8 | 99.7 | 116.0 | 71.4 | 57.4 | 62.9 |
Total Non-Current Assets | 153.0 | 143.4 | 130.2 | 111.5 | 106.3 | 104.0 | 93.7 | 60.1 | 53.9 | 54.0 | 57.3 | 59.1 |
Total Assets | 359.6 | 328.4 | 264.1 | 230.7 | 211.4 | 226.8 | 189.5 | 159.8 | 169.9 | 125.4 | 114.8 | 122.0 |
Total Current Liabilities | 165.4 | 130.1 | 109.1 | 109.5 | 90.8 | 99.8 | 77.8 | 72.9 | 99.4 | 61.4 | 43.1 | 55.5 |
Total Non-Current Liabilities | 42.3 | 47.8 | 24.3 | 17.3 | 24.9 | 23.2 | 26.0 | 25.4 | 41.1 | 40.8 | 45.4 | 28.4 |
Shareholder's Funds | 152.0 | 150.6 | 130.8 | 103.9 | 95.7 | 103.8 | 85.7 | 61.5 | 29.4 | 23.2 | 26.3 | 38.1 |
Total Liabilities | 359.6 | 328.4 | 264.1 | 230.7 | 211.4 | 226.8 | 189.5 | 159.8 | 169.9 | 125.4 | 114.8 | 122.0 |
The Industry Price to BV stands at 6.10, vs the Price to BV of 0.00, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.76, vs the Quick Ratio of 0.00, which results in a Negative aspect.
The Industry Current Ratio stands at 2.51, vs the Current Ratio of 0.00, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.19, vs the Debt to Equity Ratio of 0.00, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 372.3 | 451.1 | 384.7 | 282.4 | 227.6 | 279.4 | 302.9 | 295.0 | 220.6 | 122.5 | 125.3 | 153.2 |
Total Expenditure | 346.7 | 402.0 | 326.7 | 258.7 | 217.9 | 232.5 | 257.0 | 257.5 | 200.2 | 112.9 | 129.7 | 139.1 |
Operating Profit(Excl OI) | 26.0 | 49.1 | 58.0 | 24.9 | 10.0 | 47.7 | 46.2 | 37.7 | 20.5 | 9.9 | -2.8 | 15.0 |
Add: Other Income | 0.4 | 0.1 | 0.0 | 1.2 | 0.3 | 0.8 | 0.3 | 0.2 | 0.1 | 0.2 | 1.6 | 1.0 |
Operating Profit | 26.0 | 49.1 | 58.0 | 24.9 | 10.0 | 47.7 | 46.2 | 37.7 | 20.5 | 9.9 | -2.8 | 15.0 |
Less: Interest | 12.8 | 11.2 | 9.3 | 10.4 | 8.7 | 11.8 | 10.0 | 9.3 | 10.3 | 9.7 | 10.0 | 10.2 |
PBDT | 13.2 | 38.0 | 48.7 | 14.5 | 1.4 | 35.9 | 36.2 | 28.4 | 10.2 | 0.1 | -12.9 | 4.9 |
Less: Depreciation Amortization | 11.0 | 10.3 | 9.2 | 8.2 | 7.1 | 6.6 | 5.0 | 4.4 | 4.2 | 4.0 | 3.9 | 3.7 |
PBT & Exceptional Items | 2.2 | 27.7 | 39.5 | 6.3 | -5.7 | 29.4 | 31.2 | 24.0 | 6.0 | -3.9 | -16.8 | 1.1 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 2.2 | 27.7 | 39.5 | 6.3 | -5.7 | 29.4 | 31.2 | 24.0 | 6.0 | -3.9 | -16.8 | 1.1 |
Less: Taxation | 0.9 | 8.1 | 11.6 | -2.0 | 2.3 | 9.5 | 8.9 | 8.0 | -0.1 | -0.9 | -5.0 | 0.5 |
Profit After Tax | 1.3 | 19.7 | 28.0 | 8.3 | -8.0 | 19.9 | 22.3 | 16.0 | 6.1 | -3.0 | -11.8 | 0.6 |
Earnings Per Share | 0.0 | 0.1 | 0.2 | 0.1 | -0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | -0.1 | 0.0 |
The Industry Dividend Yield stands at 0.59, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PE Ratio stands at 41.97, vs the PE Ratio of 0.00, which results in a Negative aspect.
The Industry PAT Growth stands at 43.50, vs the PAT Growth of 0.00, which results in a Negative aspect.
The Industry PAT Margin stands at 9.77, vs the PAT Margin of 0.00, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 2.2 | 27.7 | 39.5 | 6.3 | -5.7 | 29.3 | 31.2 | 24.0 | 6.0 | -3.9 | -16.8 | 1.1 |
Tax Paid | 0.0 | -8.8 | -9.3 | -0.1 | 0.0 | -6.3 | -7.3 | -3.9 | -0.1 | -0.1 | -0.1 | -0.6 |
Adjustment | 23.9 | 22.4 | 17.2 | 18.7 | 16.2 | 18.3 | 17.4 | 13.9 | 14.5 | 13.8 | 13.9 | 13.8 |
Changes In Working Capital | 2.2 | 27.7 | 39.5 | 6.3 | -5.7 | 29.3 | 31.2 | 24.0 | 6.0 | -3.9 | -16.8 | 1.1 |
Cash Flow after changes in Working Capital | 39.5 | 34.5 | 36.8 | 30.6 | 21.7 | 30.8 | 50.1 | 25.8 | 14.0 | 7.6 | -0.6 | 7.6 |
Cash Flow from Operating Activities | 39.5 | 25.7 | 27.5 | 30.5 | 21.7 | 24.6 | 42.8 | 21.8 | 14.0 | 7.5 | -0.7 | 7.1 |
Cash Flow from Investing Activities | -22.2 | -27.3 | -31.3 | -6.9 | -9.3 | -16.0 | -39.4 | -10.9 | -3.8 | -2.3 | -2.1 | -6.2 |
Cash Flow from Financing Activities | -16.6 | 3.0 | 2.7 | -23.5 | -11.4 | -8.8 | -3.2 | -11.1 | -9.5 | -5.2 | 1.8 | -0.5 |
Net Cash Inflow / Outflow | 0.7 | 1.4 | -1.0 | 0.2 | 1.0 | -0.2 | 0.1 | -0.2 | 0.6 | 0.0 | -0.9 | 0.3 |
Opening Cash & Cash Equivalents | 1.9 | 0.6 | 1.6 | 1.4 | 0.4 | 0.6 | 0.5 | 0.7 | 0.1 | 0.1 | 1.0 | 0.7 |
Closing Cash & Cash Equivalent | 2.7 | 1.9 | 0.6 | 1.6 | 1.4 | 0.4 | 0.6 | 0.5 | 0.7 | 0.1 | 0.1 | 1.0 |
The Industry PFCF Ratio stands at 38.96, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
The Industry PCF RATIO stands at 27.38, vs the PCF RATIO of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 973.4 | 815.6 | 874.7 | 911.1 | 633.3 | 1,083.3 | 1,095.0 | 1,209.6 | 938.4 | 1,142.0 | 1,047.8 | 907.9 | 886.9 | 970.3 | 1,036.4 | 881.0 |
Total Income | 973.4 | 815.9 | 874.9 | 914.0 | 634.6 | 1,083.3 | 1,095.0 | 1,209.6 | 1,018.8 | 1,230.2 | 1,053.0 | 929.0 | 899.6 | 977.1 | 1,043.0 | 885.5 |
Total Expenditure | 903.6 | 793.6 | 909.4 | 908.7 | 568.6 | 998.9 | 991.2 | 1,107.6 | 875.7 | 1,092.6 | 944.3 | 813.3 | 760.9 | 794.1 | 900.2 | 809.4 |
PBIDT (Excl OI) | 69.8 | 21.9 | -34.7 | 2.4 | 64.7 | 84.3 | 103.8 | 102.0 | 62.7 | 49.4 | 103.5 | 94.6 | 126.0 | 176.2 | 136.2 | 71.6 |
Other Income | 0.0 | 0.3 | 0.2 | 2.9 | 1.4 | 0.0 | 0.1 | 0.0 | 80.4 | 88.2 | 5.2 | 21.1 | 12.7 | 6.8 | 6.6 | 4.5 |
Operating Profit | 69.8 | 22.2 | -34.5 | 5.4 | 66.0 | 84.3 | 103.8 | 102.0 | 143.1 | 137.6 | 108.7 | 115.7 | 138.7 | 183.0 | 142.7 | 76.1 |
Interest | 33.1 | 32.5 | 34.1 | 34.3 | 32.2 | 25.6 | 35.5 | 25.3 | 26.9 | 29.8 | 29.6 | 22.2 | 23.5 | 26.0 | 21.6 | 24.6 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 36.7 | -10.2 | -68.7 | -29.0 | 33.9 | 58.8 | 68.4 | 76.7 | 116.3 | 107.8 | 79.1 | 93.6 | 115.2 | 157.0 | 121.1 | 51.5 |
Depreciation | 36.2 | 37.3 | 34.2 | 27.5 | 28.8 | 27.6 | 26.0 | 26.9 | 26.7 | 25.0 | 23.9 | 25.2 | 23.3 | 22.7 | 20.6 | 21.0 |
Profit Before Tax | 0.4 | -47.5 | -102.9 | -56.5 | 5.0 | 31.2 | 42.4 | 49.8 | 89.5 | 82.8 | 55.2 | 68.4 | 91.9 | 134.4 | 100.5 | 30.5 |
Tax | -4.6 | -11.9 | -7.5 | -12.6 | 0.8 | 9.0 | 12.3 | -17.1 | 49.3 | 37.6 | 11.0 | 46.9 | 27.6 | 23.5 | 17.6 | -20.0 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 5.0 | -35.6 | -95.4 | -43.9 | 4.3 | 22.3 | 30.1 | 66.9 | 40.2 | 45.3 | 44.2 | 21.5 | 64.3 | 110.9 | 83.0 | 50.5 |
Net Profit | 5.0 | -35.6 | -95.4 | -43.9 | 4.3 | 22.3 | 30.1 | 66.9 | 40.2 | 45.3 | 44.2 | 21.5 | 64.3 | 110.9 | 83.0 | 50.5 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 | 158.3 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 0.3 | -2.3 | -6.0 | -2.8 | 0.3 | 1.4 | 1.9 | 4.2 | 2.5 | 2.9 | 2.8 | 1.4 | 4.1 | 7.0 | 5.2 | 3.2 |
Operating Profit Margin | 7.2 | 2.7 | -3.9 | 0.6 | 10.4 | 7.8 | 9.5 | 8.4 | 15.3 | 12.0 | 10.4 | 12.7 | 15.6 | 18.9 | 13.8 | 8.6 |
Net Profit Margin | 0.5 | -4.4 | -10.9 | -4.8 | 0.7 | 2.1 | 2.7 | 5.5 | 4.3 | 4.0 | 4.2 | 2.4 | 7.3 | 11.4 | 8.0 | 5.7 |
The Industry Net Sales Growth stands at 10.04, vs the Net Sales Growth of 0.00, which results in a Negative aspect.
The Industry Mcap Growth stands at -4.45, vs the Mcap Growth of -4.86, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 103.50 | 109.98 | 95.24 |
R3 | 101.17 | 100.65 | 93.67 |
R2 | 98.83 | 98.58 | 93.15 |
R1 | 95.47 | 94.95 | 92.62 |
Pivot | 93.13 | 92.88 | 93.13 |
S1 | 89.77 | 89.25 | 91.58 |
S2 | 87.43 | 87.18 | 91.06 |
S3 | 84.07 | 83.55 | 90.53 |
S4 | 80.70 | 75.78 | 88.97 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
0.00
Bullish
RSI
28.99
Bullish
ROC
-24.54
Bearish
UltimateOscillator
22.28
Bearish
Williams Indicator
-96.56
Bullish
CCI Indicator
-113.99
Bullish
MACD
-2,881.35
Bearish
Stochastic Indicator
3.19
Bullish
ATR
6.60
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
13-02-2024 | Quarterly Results |
08-11-2023 | Quarterly Results |
10-08-2023 | Quarterly Results |
30-05-2023 | Audited Results |
13-02-2023 | Quarterly Results |
11-11-2022 | Quarterly Results |
05-08-2022 | Quarterly Results |
26-05-2022 | Audited Results & Quarterly Results |
04-02-2022 | Quarterly Results |
12-11-2021 | Quarterly Results |
12-08-2021 | Quarterly Results |
20-05-2021 | Audited Results |